The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...
Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...
NEW YORK--(BUSINESS WIRE)--Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX Ventures with participation from Floating Point ...
With new backing from AIX Ventures, Peter Thiel, and healthcare and AI pioneers, Ataraxis AI is positioned to rapidly bring its first offering, Ataraxis Breast, to market Ataraxis AI, the leading ...
Family and gender-based violence can have lasting impacts on physical and mental health and be at the root of public health issues, such as substance use, suicide and self-harm, anxiety, depression ...
Thinaer today announces the release of Sonar 6.0.0, a transformative upgrade that sets a new standard in geospatial insights and overall platform performance. This release introduces the highly ...
Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results